Results 111 to 120 of about 88,543 (339)
Biomimetic Cell Membrane‐Coated Scaffolds for Enhanced Tissue Regeneration
Advanced Materials, EarlyView.This review examines the development and use of cell membrane‐coated scaffolds in tissue engineering. Bioinspired phospholipid and glycocalyx coatings enhance anti‐fouling, anti‐thrombogenic, and selective molecular recognition properties. Native cell membrane coatings further support cell‐specific interactions, immune modulation, and reduced bacterial
Carmen Alvarez‐Lorenzo +5 more
wiley +1 more source
Performance evaluation of a pulsatile ventricular assist device under non physiologic pumping frequencies by means FEM and 2D approach [PDF]
, 2017 A ventricular assist device (VAD) is a blood pump that works in parallel with heart. It is used as a mechanical assistance for patients that suffer cardiac insufficiency: as a therapy, as a bridge to transplant or to extend life.
Di Paolo, José, Fríes, Exequiel R.
core
Permanent ventricular assist device support versus cardiac transplantation [PDF]
, 1999 D. Glenn Pennington +2 more
openalex +1 more source
Advanced Materials, EarlyView.ENDO lipid nanoparticles containing cholecalciferol as a fifth component demonstrate mRNA delivery to the pancreas with 99% selectivity, including beta cells. This platform shows minimal toxicity and sustained protein expression for up to 3 days in a dose‐dependent manner, offering a novel approach to pancreas‐specific mRNA delivery and gene therapy ...
Ivan Isaac +7 more
wiley +1 more source
Advances in Mechanical Circulatory Support (MCS): Literature Review
BiomedicinesHeart failure is a heterogeneous disorder that can lead to cardiogenic shock. Mechanical circulatory support (MCS) devices can replace the cardiac function in an attempt to bridge patients to transplant or they can serve as destination therapy to improve
Jasmine K. Dugal +5 more
doaj +1 more source
Cardiac transplantation and ventricular assist devices
Medicine, 2010 Abstract Achieving 85% hospital discharge and 50% 10-year survival cardiac transplantation has proven benefit for terminally ill patients (Status I) with refractory heart failure. Randomized clinical trials are needed to assess benefit for ambulatory (Status II) patients.
openaire +2 more sources
Intravenous Immunoglobulin Reduces Anti-HLA Alloreactivity and Shortens Waiting Time to Cardiac Transplantation in Highly Sensitized Left Ventricular Assist Device Recipients [PDF]
, 1999 Ranjit John +9 more
openalex +1 more source
New Perspectives on Semiconducting Conjugated Oligomers for Neuromodulation in Hydra vulgaris
Advanced Materials Interfaces, EarlyView.Semiconducting organic compounds, thiophene‐based, modify the rhythmic electrical activity of the cnidarian Hydra vulgaris acting on specific neuronal circuits. The ETE‐S trimer also forms electronically conducting wires in the living tissues of the animal.
Giuseppina Tommasini +7 more
wiley +1 more source
Advanced Intelligent SystemsHeart failure occurs when the heart cannot pump adequate blood to the body, which afflicts over 60 million people worldwide. Its treatment options include physiotherapy, medication, mechanical heart support, heart surgery, or heart transplantation ...
Phuoc Thien Phan +12 more
doaj +1 more source
Advanced Materials Technologies, EarlyView.This article presents a novel strategy for creating highly stretchable wireless circuits using electrical metamaterial‐based interconnects (EMIs). Embedded in soft polymers and filled with liquid metal, EMIs uniquely reduce resistance under strain. A fully integrated ECG circuit demonstrates reliable performance under 100% stretch, offering a highly ...
Anan Zhang +2 more
wiley +1 more source